RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia cases: gentler treatment trial opens for elderly
Disease control Recruiting nowThis study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin) with lower-intensity chemotherapy and immunotherapy for adults with a type of blood cancer called acute lymphoblastic leukemia (ALL). It focuses on patients aged 60 and older, or younger adults …
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 21:11 UTC
-
New Two-Pronged attack tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a two-step treatment for a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). It is for older adults who are newly diagnosed or for adults whose cancer has come back or hasn't responded to other treatments. The treatment first uses a targ…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Two-Drug combo aims to tame tough leukemia relapse in kids
Disease control Recruiting nowThis study is testing if adding the drug nivolumab to a standard immunotherapy (blinatumomab) works better for controlling B-cell acute lymphoblastic leukemia (B-ALL) that has come back after initial treatment. It is for children and young adults aged 1 to 31 who have had their f…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New 'Double-Target' cell therapy tested in kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis early-stage study is testing the safety of a new type of CAR T-cell therapy for children and young adults (up to age 21) whose acute lymphoblastic leukemia has come back or hasn't responded to other treatments. The therapy uses the patient's own modified immune cells designe…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists test new pill cocktail in fight against tough leukemia
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a new combination of oral pills (venetoclax and dasatinib) for adults with a specific, aggressive type of blood cancer called Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) or mixed phenotype acute…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Targeted missile drug tested in kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a drug called inotuzumab ozogamicin for children and young adults whose B-cell leukemia has come back or hasn't responded to other treatments. The drug is designed to find and kill only the cancer cells. Researchers want to see how well it works and how safe…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC